Roy Poses has an interesting post on the Health Care Renewal blog, where he looks at some of of the interrelationships between the parties and some of the financial details in the case.
[In my “Economics of Kelo” post, I simplified the actual relationship between Pfizer and the City of New London and the New London Development Corporation in order to try to get to the larger question of the role of “public use” in the case. I don’t think it changes the analysis of the basic constitutional question and what the Court decided, which is why I used “Pfizer” as a shorthand reference to the private parties in the case in my post. Those looking for a more detailed summary of the facts can find it in Dr. Poses’s post.]
Comments are closed.